| Value | ₹1.95 Cr |
|---|
BSE filing, BSE: 543500. Summary written from the filing by ALFA Finder's alert engine.
Evoq Remedies Ltd: key numbers
- Share price
- ₹1.61
- Market cap
- ₹4.01 Cr
- Revenue (annual)
- ₹25.51 Cr
- Net profit (annual)
- ₹-0.24 Cr
- P/E (TTM)
- -16.7×Sector 52.0×
- Promoter holding
- 0.02%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Evoq Remedies Ltd
All →Evoq Remedies Other Announcement
Evoq Remedies Ltd received approval from the Registrar of Companies to extend the deadline for its 16th Annual General Meeting until 30th October 2026.
Evoq Remedies Insolvency Petition
An operational creditor has filed an insolvency petition against Evoq Remedies under IBC Section 9. The NCLT admission initiates the CIRP process, posing significant risk for shareholders.
Evoq Remedies Financial Results
Evoq Remedies Limited reported audited financial results for the year ended March 31, 2026. The auditor issued a qualified opinion citing material uncertainty regarding going concern.
Evoq Remedies H2 FY26 Results: Net Loss of ₹0.3 Cr
Evoq Remedies Ltd reported a net loss of ₹0.3 Cr for H2 FY26.
- Key figure
- Net loss ₹0.3 Cr
Evoq Remedies Financial Results
Evoq Remedies Limited reported annual revenue of ₹26.76 Crore for FY2026. The board also appointed M/s. Jay Pandya & Associates as secretarial auditors for FY2025-26.
- Value
- ₹26.76 Cr
Evoq Remedies Board Meeting Date
Evoq Remedies rescheduled its board meeting from May 27 to May 30, 2026. Directors will consider audited financial results for the fiscal year ended March 31.
Other insolvency petition announcements
All →BIL Vyapar Insolvency Petition
Bil Vyapar Ltd, under CIRP, intimated its 21st Committee of Creditors meeting for October 29, 2026. No monetary amount or resolution plan details are disclosed.
Polycab India Insolvency Petition
NCLAT directed MSCI not to delist Polycab from its Index pending the insolvency appeal order. The interim direction preserves index inclusion during the CIRP appeal.
Premier Insolvency Petition
Premier Limited (in CIRP) intimated that its 21st CoC meeting was rescheduled from December 11 to December 12, 2025. The Resolution Professional filed this under SEBI Regulation 30 for exchange record.
CMI Insolvency Petition
CMI Limited, a Corporate Debtor under CIRP, intimated its 49th Committee of Creditors meeting scheduled for 27 October 2026. No resolution details are disclosed.
DPSC Insolvency Petition
DPSC Limited (under CIRP) reported that its 8th CoC meeting approved all remaining agenda items except consultancy fees to a related party. No new monetary value or resolution plan outcome is disclosed.
Shrenik Insolvency Petition
Shrenik Limited's resolution professional disclosed the third Committee of Creditors meeting under CIRP, scheduled for 22 October 2026. The filing is procedural and includes no monetary amount.